Literature DB >> 24286866

Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine.

Olga Schweigert1, Christin Dewitz1, Katja Möller-Hackbarth1, Ahmad Trad1, Christoph Garbers2, Stefan Rose-John1, Jürgen Scheller3.   

Abstract

T cell immunoglobulin and mucin domain 1 and 4 (TIM-1 and -4) proteins serve as phosphatidylserine receptors to engulf apoptotic cells. Here we show that human TIM-1 and TIM-4 proteins are targets of A Disintegrin And Metalloprotease (ADAM)-mediated ectodomain shedding resulting in soluble forms of TIM-1 and TIM-4. We identified ADAM10 and ADAM17 as major sheddases of TIM-1 and TIM-4 as shown by protease-specific inhibitors, the ADAM10 prodomain, siRNA and ADAM10/ADAM17 deficient murine embryonic fibroblasts (MEFs). TIM-1 and TIM-4 lacking the intracellular domain were efficiently cleaved after ionomycin- and PMA-treatment, indicating that the intracellular domain was not necessary for ectodomain shedding. Soluble TIM-1 and -4 were able to bind to phosphatidylserine, suggesting that soluble TIM-1 and -4 might act as negative regulators of cellular TIM-1 and -4. In summary, we describe TIM-1 and TIM-4 as novel targets for ADAM10- and ADAM17-mediated ectodomain shedding.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADAM; Cell surface receptor; DMEM; Dulbecco's modified Eagle's medium; FBS; Shedding; T cell immunoglobulin and mucin domain protein; fetal bovine serum; mAb; monoclonal antibody

Mesh:

Substances:

Year:  2013        PMID: 24286866     DOI: 10.1016/j.bbamcr.2013.11.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.

Authors:  Kiera L Clayton; Matthew B Douglas-Vail; A K M Nur-ur Rahman; Karyn E Medcalf; Irene Y Xie; Glen M Chew; Ravi Tandon; Marion C Lanteri; Philip J Norris; Steven G Deeks; Lishomwa C Ndhlovu; Mario A Ostrowski
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

2.  Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

Authors:  Saranga Sriranganathan; Elena Tutunea-Fatan; Alina Abbasi; Lakshman Gunaratnam
Journal:  Mol Cell Biochem       Date:  2020-11-19       Impact factor: 3.396

Review 3.  Regulation of T cell responses by the receptor molecule Tim-3.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

4.  How Tim proteins differentially exploit membrane features to attain robust target sensitivity.

Authors:  Daniel Kerr; Zhiliang Gong; Tiffany Suwatthee; Adrienne Luoma; Sobhan Roy; Renee Scarpaci; Hyeondo Luke Hwang; J Michael Henderson; Kathleen D Cao; Wei Bu; Binhua Lin; Gregory T Tietjen; Theodore L Steck; Erin J Adams; Ka Yee C Lee
Journal:  Biophys J       Date:  2021-09-14       Impact factor: 4.033

5.  T-Cell Immunoglobulin and Mucin Domain-Containing Protein-4 Is Critical for Kupffer Cell Homeostatic Function in the Activation and Resolution of Liver Ischemia Reperfusion Injury.

Authors:  Ming Ni; Jing Zhang; Rebecca Sosa; Hanwen Zhang; Han Wang; Dan Jin; Kaitlyn Crowley; Bita Naini; F Elaine Reed; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Xuehao Wang; Yuan Zhai
Journal:  Hepatology       Date:  2021-08-10       Impact factor: 17.298

Review 6.  Immune Regulation and Antitumor Effect of TIM-1.

Authors:  Peng Du; Ruihua Xiong; Xiaodong Li; Jingting Jiang
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

Review 7.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

8.  KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.

Authors:  Mohammad M Al-Bataineh; Carol L Kinlough; Zaichuan Mi; Edwin K Jackson; Stephanie M Mutchler; David R Emlet; John A Kellum; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-21

Review 9.  Targeting phosphatidylserine for Cancer therapy: prospects and challenges.

Authors:  Wenguang Chang; Hongge Fa; Dandan Xiao; Jianxun Wang
Journal:  Theranostics       Date:  2020-07-23       Impact factor: 11.556

Review 10.  Efferocytosis and autoimmune disease.

Authors:  Mahiru Kawano; Shigekazu Nagata
Journal:  Int Immunol       Date:  2018-11-14       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.